Preoperative Treatment of Patients With High Risk Thymoma
Condition(s):ThymomaLast Updated:December 9, 2014Completed
Hide Studies Not Open or Pending
Condition(s):ThymomaLast Updated:December 9, 2014Completed
Condition(s):Thymoma and Thymic CarcinomaLast Updated:June 15, 2023Completed
Condition(s):Thymic Cancer; ThymomaLast Updated:June 3, 2014Completed
Condition(s):Locally Advanced Thymic Carcinoma; Metastatic Thymic Carcinoma; Recurrent Thymic Carcinoma; Unresectable Thymic CarcinomaLast Updated:May 3, 2023Active, not recruiting
Condition(s):ThymomaLast Updated:August 28, 2009Completed
Condition(s):Thymoma and Thymic CarcinomaLast Updated:December 10, 2021Unknown status
Condition(s):Thymic Epithelial Tumor; Thymic Carcinoma; Thymoma; Thymoma and Thymic CarcinomaLast Updated:March 27, 2024Recruiting
Condition(s):Invasive Thymoma and Thymic Carcinoma; Recurrent Thymoma and Thymic Carcinoma; Stage III Thymoma; Stage IVA Thymoma; Stage IVB ThymomaLast Updated:June 10, 2015Terminated
Condition(s):Thymoma; Thymus Cancer; Thymic CarcinomaLast Updated:April 16, 2019Completed
Condition(s):Stage III Thymoma AJCC v8; Stage IIIA Thymoma AJCC v8; Stage IIIB Thymoma AJCC v8; Stage IV Thymoma AJCC v8; Stage IVA Thymoma AJCC v8; Stage IVB Thymoma AJCC v8; Unresectable Thymic CarcinomaLast Updated:March 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.